Skip navigation

Leadership Seminar – Addressing Infectious Diseases Challenges

09:30 - 18:30

Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL
15 November 2017
Infectious Diseases is a vast therapeutic area. Some would claim it is the most ancient, and still in 2017, is one of the top healthcare priorities worldwide. The figures speak for themselves, anti-microbial resistance itself may be responsible for 10 million deaths per year worldwide by 2050, having a 3.5% adverse impact on GDP and costing $100 trillion to the world economy in the same timescale. 

Despite these obvious global challenges, solutions appear to be on the decline. Whilst global patent applications for new antibiotics halved between 2004 and 2013, only two antibiotics NMEs were registered with the FDA between 2008 and 2012, down from 16 in the past 30 years.*

So what is jamming the infectious diseases drug development machine? Is it related to the processes that detect and monitor pathogenic activities which may then impact on lab innovations especially on resistance activity? Could it be linked to the antibiotic/antiviral business models that don’t seem to be adaptable to these new global challenges?

This Leadership Seminar will explore these questions with contributions from industry experts who are confronted by these challenges. This should appeal to any academic, biotech, pharma or investor who wants to make a contribution to the complex area that is infectious disease. 

* These figures were taken from Peter Jackson, Executive Director of the AMR centre brilliant presentation at ON Helix 17. You can see it here.


09.30 - Registration over Tea and Coffee

10.00 - Welcome

10.10 - Overview of Industry Activity and Deals
Christopher Berry, PharmaVentures

10.30 – The Pharma Perspective on Infectious Disease Challenges
Michel de Baar, MSD

11.00 – The Molecular Agar Plate – Bringing Microbiology Out of the 19th Century
Prof John Wain, University of East Anglia

11.30 – The Biotech Perspective on Infectious Disease Challenges
David Williams, Discuva

11.50 - A Collaborative Model to Support Innovation Across 4 Fields of Applied Microbiology (Microbiota, Vaccines, Antimicrobials, Diagnostics)
Alexis Rideau, Bioaster

12.15 - Lunch

13.30 - Innovative Approach to Pathogen Resistance and Detection

13.30 - ReViral: Targeting Respiratory Syncytial Virus
Rachel Harland, ReViral

13.55 - Prevention of Bacterial Infections to Address AMR
Fiona Marston, ABsynth Biologics

14.20 - Innovative Approach to Pathogen Resistance
Richard Rutter, Auspherix

14.45 - Coffee Break

15.15 - Semiconductor-Based IVD Directing Antimicrobial Therapy
Brian McKeown, DNAe

15.40 - Oxitec’s Self-Limiting Mosquitoes for Management of Vectors of Human Disease
Catherine Reavey, Oxitec

16.05 - New Models to Incentivize and Support Early Stage R&D in the AMR Space
Peter Jackson, The AMR Centre
Heather Shane, California Life Sciences Institute CARB-X Accelerator

16.40 - Closing Remarks

16.45 - Networking over Drinks

18.00 - Close

Gold Members: £75 +VAT 
Silver Members: £175 +VAT 
Non-Members: £275 +VAT
Academics: £75 + VAT – please contact for your discount code.

Title: Leadership Seminar – Addressing Infectious Diseases Challenges
Start: 2017-11-15 09:30:00Z
End: 2017-11-15 18:30:00Z